Epigenetic reactivation of RANK in glioblastoma cells by curcumin: Involvement of STAT3 inhibition

DNA and Cell Biology

Volumn 32, Issue 6, 2013, Pages 292-297

  Wu, Bingshan ^a,b,c   Yao, Xueqin ^b,c   Nie, Xiaohu ^a,b,c   Xu, Ruxiang ^a,b,c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Beijing Institute of Neurosurgery   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; CURCUMIN; MESSENGER RNA; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; STAT3 PROTEIN;

ARTICLE; CONCENTRATION (PARAMETERS); DEMETHYLATION; EPIGENETICS; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CPG ISLANDS; CURCUMIN; DNA METHYLATION; DNA-CYTOSINE METHYLASES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; PROMOTER REGIONS, GENETIC; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; STAT3 TRANSCRIPTION FACTOR;

CURCUMA LONGA;

EID: 84878434082     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2042     Document Type: Article

References (26)

1. Bharti, A. C., and Aggarwal, B. B. (2004). Ranking the role of RANK ligand in apoptosis. Apoptosis 9, 677-690.
2. Cedar, H., and Bergman, Y. (2009). Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10, 295-304.
3. Du, L., Xie, Z., Wu, L. C., Chiu, M., Lin, J., Chan, K. K., Liu, S., and Liu, Z. (2012). Reactivation of RASSF1A in breast cancer cells by curcumin. Nutr Cancer 64, 1228-1235.
4. Georgakis, G. V., Li, Y., Rassidakis, G. Z., Medeiros, L. J., Mills, G. B., and Younes, A. (2006). Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma. Br J Haematol 132, 503-511.
5. Hanada, R., Hanada, T., Sigl, V., Schramek, D., and Penninger, J. M. (2011). RANKL/RANK-beyond bones. J Mol Med (Berl) 89, 647-656.
6. Hardy, T. M., and Tollefsbol, T. O. (2011). Epigenetic diet: impact on the epigenome and cancer. Epigenomics 3, 503-518.
7. Lee, H., Zhang, P., Herrmann, A., Yang, C., Xin, H., Wang, Z., Hoon, D. S., Forman, S. J., Jove, R., Riggs, A. D., et al. (2012). Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc Natl Acad Sci U S A 109, 7765-7769.
8. Liao, X., Lochhead, P., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M., Imamura, Y., Qian, Z. R., Baba, Y., Shima, K., et al. (2012). Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 367, 1596-1606.
9. Liu, Z., Xie, Z., Jones, W., Pavlovicz, R. E., Liu, S., Yu, J., Li, P. K., Lin, J., Fuchs, J. R., Marcucci, G., et al. (2009). Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett 19, 706-709.
10. Maeda, K., Kobayashi, Y., Udagawa, N., Uehara, S., Ishihara, A., Mizoguchi, T., Kikuchi, Y., Takada, I., Kato, S., Kani, S., et al. (2012). Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat Med 18, 405-412.
11. Mathews, L. A., Hurt, E. M., Zhang, X., and Farrar, W. L. (2010). Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells. Mol Cancer 9, 267.
12. Mori, T., Miyamoto, T., Yoshida, H., Asakawa, M., Kawasumi, M., Kobayashi, T., Morioka, H., Chiba, K., Toyama, Y., and Yoshimura, A. (2011). IL-1beta and TNFalpha-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. Int Immunol 23, 701-712.
13. Papanastasiou, A. D., Sirinian, C., and Kalofonos, H. P. (2012). Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration. Breast Cancer Res 14, R112.
14. Ravindran, J., Prasad, S., and Aggarwal, B. B. (2009). Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11, 495-510.
15. Reuter, S., Gupta, S. C., Park, B., Goel, A., and Aggarwal, B. B. (2011). Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr 6, 93-108.
16. Riegel, A., Maurer, T., Prior, B., Stegmaier, S., Heppert, V., Wagner, C., and Hansch, G. M. (2012). Human polymorphonuclear neutrophils express RANK and are activated by its ligand, RANKL. Eur J Immunol 42, 975-981.
17. Roberts, N. A., White, A. J., Jenkinson, W. E., Turchinovich, G., Nakamura, K., Withers, D. R., McConnell, F. M., Desanti, G. E., Benezech, C., Parnell, S. M., et al. (2012). Rank signaling links the development of invariant gammadelta T cell progenitors and Aire( + ) medullary epithelium. Immunity 36, 427-437.
18. Saydmohammed, M., Joseph, D., and Syed, V. (2010). Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells. J Cell Biochem 110, 447-456.
19. Schramek, D., Leibbrandt, A., Sigl, V., Kenner, L., Pospisilik, J. A., Lee, H. J., Hanada, R., Joshi, P. A., Aliprantis, A., Glimcher, L., et al. (2010). Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468, 98-102.
20. Shu, L., Khor, T. O., Lee, J. H., Boyanapalli, S. S., Huang, Y., Wu, T. Y., Saw, C. L., Cheung, K. L., and Kong, A. N. (2011). Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J 13, 606-614.
21. Tsujioka, T., Matsuoka, A., Tohyama, Y., and Tohyama, K. (2012). Approach to new therapeutics: investigation by the use of MDS-derived cell lines. Curr Pharm Des 18, 3204-3214.
22. von dem Knesebeck, A., Felsberg, J., Waha, A., Hartmann, W., Scheffler, B., Glas, M., Hammes, J., Mikeska, T., Yan, P. S., Endl, E., et al. (2012). RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas. Neoplasia 14, 526-534.
23. Yi, T., Lee, H. L., Cha, J. H., Ko, S. I., Kim, H. J., Shin, H. I., Woo, K. M., Ryoo, H. M., Kim, G. S., and Baek, J. H. (2008). Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. J Cell Physiol 217, 409-422.
24. Yoo, C. B., and Jones, P. A. (2006). Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 5, 37-50.
25. Zhang, Q., Wang, H. Y., Marzec, M., Raghunath, P. N., Nagasawa, T., and Wasik, M. A. (2005). STAT3-and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci U S A 102, 6948-6953.
26. Zhang, Q., Wang, H. Y., Woetmann, A., Raghunath, P. N., Odum, N., and Wasik, M. A. (2006). STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood 108, 1058-1064.